These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 26283544)

  • 21. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells.
    Cheng YP; Li S; Chuang WL; Li CH; Chen GJ; Chang CC; Or CR; Lin PY; Chang CC
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
    Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.
    McFarland BC; Gray GK; Nozell SE; Hong SW; Benveniste EN
    Mol Cancer Res; 2013 May; 11(5):494-505. PubMed ID: 23386688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Stat3 in glioblastoma multiforme.
    Luwor RB; Stylli SS; Kaye AH
    J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
    Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. d,l-Sulforaphane Induces ROS-Dependent Apoptosis in Human Gliomablastoma Cells by Inactivating STAT3 Signaling Pathway.
    Miao Z; Yu F; Ren Y; Yang J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.
    Zappavigna S; Scuotto M; Cossu AM; Ingrosso D; De Rosa M; Schiraldi C; Filosa R; Caraglia M
    J Exp Clin Cancer Res; 2016 Oct; 35(1):167. PubMed ID: 27770821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.
    Liu J; Xu X; Feng X; Zhang B; Wang J
    J Exp Clin Cancer Res; 2011 Sep; 30(1):80. PubMed ID: 21906308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
    Jorvig JE; Chakraborty A
    Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures.
    Ivanov VN; Grabham PW; Wu CC; Hei TK
    Sci Rep; 2020 Feb; 10(1):2687. PubMed ID: 32060308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
    Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
    Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 as a Therapeutic Target for Glioblastoma.
    Liu Y; Li C; Lin J
    Anticancer Agents Med Chem; 2010 Sep; 10(7):512-9. PubMed ID: 20879983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
    Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
    Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Casticin induces apoptosis and cytoprotective autophagy while inhibiting stemness involving Akt/mTOR and JAK2/STAT3 pathways in glioblastoma.
    Yang X; Liu Z; Xu X; He M; Xiong H; Liu L
    Phytother Res; 2024 Jan; 38(1):305-320. PubMed ID: 37869765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells.
    Chiang YC; Selvam P; Liu YX; Shih PC; Chen NF; Kuo HM; Lin HY; Wen ZH; Chen WF
    Environ Toxicol; 2024 Jun; 39(6):3292-3303. PubMed ID: 38415901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.
    Wang Y; Yang C; Sims MM; Sacher JR; Raje M; Deokar H; Yue P; Turkson J; Buolamwini JK; Pfeffer LM
    Cancer Lett; 2022 May; 533():215614. PubMed ID: 35245627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.